Laobaixing Pharmacy (603883) — Cash Flow Quality Index
Laobaixing Pharmacy (603883) has a Cash Flow Quality Index of 4.12x as of September 2025. Operating cash flow of CN¥538.25 Million exceeds net income of CN¥130.78 Million, indicating high earnings quality where cash backs reported profits. Explore 603883 operating cash flow to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Laobaixing Pharmacy Cash Flow Quality Index (2012–2025)
Historical Cash Flow Quality Index for Laobaixing Pharmacy across 14 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check 603883 capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Laobaixing Pharmacy (2012–2025)
Year-by-year earnings quality comparison for Laobaixing Pharmacy. For live market cap and the full company financial profile, see Laobaixing Pharmacy market cap and net worth.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 8.23x | CN¥3.14 Billion | CN¥381.85 Million | ▲ +110.8% |
| 2024 | 3.90x | CN¥2.03 Billion | CN¥519.06 Million | ▲ +32.9% |
| 2023 | 2.94x | CN¥2.73 Billion | CN¥929.02 Million | ▲ +23.9% |
| 2022 | 2.37x | CN¥2.31 Billion | CN¥976.24 Million | ▼ -18.9% |
| 2021 | 2.92x | CN¥2.30 Billion | CN¥786.73 Million | ▲ +54.3% |
| 2020 | 1.89x | CN¥1.45 Billion | CN¥764.48 Million | ▲ +12.8% |
| 2019 | 1.68x | CN¥1.03 Billion | CN¥614.98 Million | ▼ -7.3% |
| 2018 | 1.81x | CN¥913.03 Million | CN¥504.00 Million | ▲ +46.1% |
| 2017 | 1.24x | CN¥492.13 Million | CN¥396.86 Million | ▲ +35.4% |
| 2016 | 0.92x | CN¥313.26 Million | CN¥342.04 Million | ▼ -1.1% |
| 2015 | 0.93x | CN¥257.15 Million | CN¥277.73 Million | ▼ -10.8% |
| 2014 | 1.04x | CN¥247.14 Million | CN¥238.00 Million | ▲ +47.3% |
| 2013 | 0.71x | CN¥136.52 Million | CN¥193.63 Million | ▼ -26.4% |
| 2012 | 0.96x | CN¥148.85 Million | CN¥155.38 Million | — |